• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients Who Have Had a Myocardial Infarction".

作者信息

Wang Ziteng, Chan Koo Hui, Chan Eric Chun Yong

机构信息

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore, 117600, Singapore.

National University Heart Centre Singapore, National University Hospital, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.

出版信息

Clin Pharmacokinet. 2025 May 23. doi: 10.1007/s40262-025-01518-z.

DOI:10.1007/s40262-025-01518-z
PMID:40408049
Abstract
摘要

相似文献

1
Comment on "Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients Who Have Had a Myocardial Infarction".关于“替格瑞洛与心肌梗死患者瑞舒伐他汀血药浓度升高相关”的评论
Clin Pharmacokinet. 2025 May 23. doi: 10.1007/s40262-025-01518-z.
2
Author's Reply to Chan et al.: "Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients Who Have Had a Myocardial Infarction".作者对陈等人的回复：“替格瑞洛与心肌梗死患者中瑞舒伐他汀血药浓度升高有关”
Clin Pharmacokinet. 2025 Jul;64(7):1137-1138. doi: 10.1007/s40262-025-01519-y. Epub 2025 May 23.
3
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
4
Drug-eluting stents versus bare-metal stents for acute coronary syndrome.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征的比较
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD012481. doi: 10.1002/14651858.CD012481.pub2.
5
Exercise-based rehabilitation for coronary heart disease.基于运动的冠心病康复治疗
Cochrane Database Syst Rev. 2000(4):CD001800. doi: 10.1002/14651858.CD001800.
6
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.应激性高血糖与糖尿病及非糖尿病心肌梗死患者死亡风险增加：一项系统综述
Lancet. 2000 Mar 4;355(9206):773-8. doi: 10.1016/S0140-6736(99)08415-9.
7
Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial Infarction.替格瑞洛与心肌梗死患者中瑞舒伐他汀血药浓度升高有关。
Clin Pharmacokinet. 2025 Apr;64(4):565-571. doi: 10.1007/s40262-025-01489-1. Epub 2025 Mar 3.
8
Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures.牙科操作后预防细菌性心内膜炎的抗生素预防。
Cochrane Database Syst Rev. 2022 May 10;5(5):CD003813. doi: 10.1002/14651858.CD003813.pub5.
9
Eplerenone for hypertension.依普利酮用于治疗高血压。
Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD008996. doi: 10.1002/14651858.CD008996.pub2.
10
WITHDRAWN: Antidepressants for depression in medical illness.撤回：用于治疗躯体疾病伴发抑郁症的抗抑郁药。
Cochrane Database Syst Rev. 2007 Jul 18;2000(4):CD001312. doi: 10.1002/14651858.CD001312.pub2.

引用本文的文献

1
Author's Reply to Chan et al.: "Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients Who Have Had a Myocardial Infarction".作者对陈等人的回复：“替格瑞洛与心肌梗死患者中瑞舒伐他汀血药浓度升高有关”
Clin Pharmacokinet. 2025 Jul;64(7):1137-1138. doi: 10.1007/s40262-025-01519-y. Epub 2025 May 23.

本文引用的文献

1
Author's Reply to Chan et al.: "Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients Who Have Had a Myocardial Infarction".作者对陈等人的回复：“替格瑞洛与心肌梗死患者中瑞舒伐他汀血药浓度升高有关”
Clin Pharmacokinet. 2025 Jul;64(7):1137-1138. doi: 10.1007/s40262-025-01519-y. Epub 2025 May 23.
2
Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial Infarction.替格瑞洛与心肌梗死患者中瑞舒伐他汀血药浓度升高有关。
Clin Pharmacokinet. 2025 Apr;64(4):565-571. doi: 10.1007/s40262-025-01489-1. Epub 2025 Mar 3.
3
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
替格瑞洛增加乳腺癌耐药蛋白底物瑞舒伐他汀的暴露量。
Clin Pharmacol Ther. 2024 Jan;115(1):71-79. doi: 10.1002/cpt.3067. Epub 2023 Oct 20.
4
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics.一项全面的药物基因组学研究表明 SLCO1B1、ABCG2 和 SLCO2B1 在瑞舒伐他汀药代动力学中的作用。
Br J Clin Pharmacol. 2023 Jan;89(1):242-252. doi: 10.1111/bcp.15485. Epub 2022 Aug 22.
5
The Association between ABCG2 421C>A (rs2231142) Polymorphism and Rosuvastatin Pharmacokinetics: A Systematic Review and Meta-Analysis.ABCG2 421C>A（rs2231142）多态性与瑞舒伐他汀药代动力学之间的关联：一项系统评价和荟萃分析。
Pharmaceutics. 2022 Feb 24;14(3):501. doi: 10.3390/pharmaceutics14030501.
6
Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese population.阿托伐他汀药代动力学建模及日本人群中BCRP基因多态性影响的鉴定。
Pharmacogenet Genomics. 2017 Jan;27(1):27-38. doi: 10.1097/FPC.0000000000000252.
7
ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control study.ABCG2基因多态性作为阿托伐他汀不良反应的危险因素：一项病例对照研究。
Pharmacogenomics. 2015 Jul;16(8):803-15. doi: 10.2217/pgs.15.47. Epub 2015 Jun 18.
8
Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote.ABCG2 34G>A和421C>A纯合子或复合杂合子的健康中国人体内瑞舒伐他汀药代动力学的显著改变
J Pharmacol Exp Ther. 2015 Sep;354(3):310-5. doi: 10.1124/jpet.115.225045. Epub 2015 Jun 16.
9
Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update.替格瑞洛：药代动力学、药效学和药物遗传学概况：最新进展
Clin Pharmacokinet. 2015 Nov;54(11):1125-38. doi: 10.1007/s40262-015-0290-2.
10
Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients.ABCG2基因多态性对中国晚期非小细胞肺癌患者酪氨酸激酶抑制剂治疗临床结局的影响
Cancer Cell Int. 2015 Apr 19;15:43. doi: 10.1186/s12935-015-0191-3. eCollection 2015.